These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 33303880)

  • 1. Cell-free DNA promotes malignant transformation in non-tumor cells.
    Souza AG; Bastos VAF; Fujimura PT; Ferreira ICC; Leal LF; da Silva LS; Laus AC; Reis RM; Martins MM; Santos PS; Corrêa NCR; Marangoni K; Thomé CH; Colli LM; Goulart LR; Goulart VA
    Sci Rep; 2020 Dec; 10(1):21674. PubMed ID: 33303880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-195 Inhibits Tumor Progression by Targeting RPS6KB1 in Human Prostate Cancer.
    Cai C; Chen QB; Han ZD; Zhang YQ; He HC; Chen JH; Chen YR; Yang SB; Wu YD; Zeng YR; Qin GQ; Liang YX; Dai QS; Jiang FN; Wu SL; Zeng GH; Zhong WD; Wu CL
    Clin Cancer Res; 2015 Nov; 21(21):4922-34. PubMed ID: 26080838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Promising noninvasive cellular phenotype in prostate cancer cells knockdown of matrix metalloproteinase 9.
    Gupta A; Cao W; Sadashivaiah K; Chen W; Schneider A; Chellaiah MA
    ScientificWorldJournal; 2013; 2013():493689. PubMed ID: 23476138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infiltrating T cells promote prostate cancer metastasis via modulation of FGF11→miRNA-541→androgen receptor (AR)→MMP9 signaling.
    Hu S; Li L; Yeh S; Cui Y; Li X; Chang HC; Jin J; Chang C
    Mol Oncol; 2015 Jan; 9(1):44-57. PubMed ID: 25135278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stromal hyaluronan interaction with epithelial CD44 variants promotes prostate cancer invasiveness by augmenting expression and function of hepatocyte growth factor and androgen receptor.
    Ghatak S; Hascall VC; Markwald RR; Misra S
    J Biol Chem; 2010 Jun; 285(26):19821-32. PubMed ID: 20200161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secreted Hsp90 is a novel regulator of the epithelial to mesenchymal transition (EMT) in prostate cancer.
    Hance MW; Dole K; Gopal U; Bohonowych JE; Jezierska-Drutel A; Neumann CA; Liu H; Garraway IP; Isaacs JS
    J Biol Chem; 2012 Nov; 287(45):37732-44. PubMed ID: 22989880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the expression of variant and standard CD44 in prostate cancer cells: identification of the possible molecular mechanism of CD44/MMP9 complex formation on the cell surface.
    Desai B; Ma T; Zhu J; Chellaiah MA
    J Cell Biochem; 2009 Sep; 108(1):272-84. PubMed ID: 19582779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA‑106b functions as an oncogene and regulates tumor viability and metastasis by targeting LARP4B in prostate cancer.
    Yin W; Chen J; Wang G; Zhang D
    Mol Med Rep; 2019 Aug; 20(2):951-958. PubMed ID: 31173237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miRNA-34b inhibits prostate cancer through demethylation, active chromatin modifications, and AKT pathways.
    Majid S; Dar AA; Saini S; Shahryari V; Arora S; Zaman MS; Chang I; Yamamura S; Tanaka Y; Chiyomaru T; Deng G; Dahiya R
    Clin Cancer Res; 2013 Jan; 19(1):73-84. PubMed ID: 23147995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel microRNA regulator of prostate cancer epithelial-mesenchymal transition.
    Bucay N; Bhagirath D; Sekhon K; Yang T; Fukuhara S; Majid S; Shahryari V; Tabatabai Z; Greene KL; Hashimoto Y; Shiina M; Yamamura S; Tanaka Y; Deng G; Dahiya R; Saini S
    Cell Death Differ; 2017 Jul; 24(7):1263-1274. PubMed ID: 28498363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. siRNA-mediated silencing of CD44 delivered by Jet Pei enhanced Doxorubicin chemo sensitivity and altered miRNA expression in human breast cancer cell line (MDA-MB468).
    Vahidian F; Safarzadeh E; Mohammadi A; Najjary S; Mansoori B; Majidi J; Babaloo Z; Aghanejad A; Shadbad MA; Mokhtarzadeh A; Baradaran B
    Mol Biol Rep; 2020 Dec; 47(12):9541-9551. PubMed ID: 33206362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extracellular vesicles as drivers of epithelial-mesenchymal transition and carcinogenic characteristics in normal prostate cells.
    Souza AG; B Silva IB; Campos-Fernández E; Marangoni K; F Bastos VA; Alves PT; Goulart LR; Alonso-Goulart V
    Mol Carcinog; 2018 Apr; 57(4):503-511. PubMed ID: 29247548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-143 inhibits cell migration and invasion by targeting matrix metalloproteinase 13 in prostate cancer.
    Wu D; Huang P; Wang L; Zhou Y; Pan H; Qu P
    Mol Med Rep; 2013 Aug; 8(2):626-30. PubMed ID: 23732700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Finasteride inhibits human prostate cancer cell invasion through MMP2 and MMP9 downregulation.
    Moroz A; Delella FK; Almeida R; Lacorte LM; Fávaro WJ; Deffune E; Felisbino SL
    PLoS One; 2013; 8(12):e84757. PubMed ID: 24386413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IDH1R132H Promotes Malignant Transformation of Benign Prostatic Epithelium by Dysregulating MicroRNAs: Involvement of IGF1R-AKT/STAT3 Signaling Pathway.
    Zhang L; Qi M; Feng T; Hu J; Wang L; Li X; Gao W; Liu H; Jiao M; Wu Z; Bai X; Bie Y; Liu L; Han B
    Neoplasia; 2018 Feb; 20(2):207-217. PubMed ID: 29331887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SULF2 overexpression positively regulates tumorigenicity of human prostate cancer cells.
    Vicente CM; Lima MA; Nader HB; Toma L
    J Exp Clin Cancer Res; 2015 Mar; 34(1):25. PubMed ID: 25887999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer stem-like cells enriched with CD29 and CD44 markers exhibit molecular characteristics with epithelial-mesenchymal transition in squamous cell carcinoma.
    Geng S; Guo Y; Wang Q; Li L; Wang J
    Arch Dermatol Res; 2013 Jan; 305(1):35-47. PubMed ID: 22740085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Golgi phosphoprotein 3 regulates metastasis of prostate cancer via matrix metalloproteinase 9.
    Li W; Qi K; Wang Z; Gu M; Chen G; Guo F; Wang Z
    Int J Clin Exp Pathol; 2015; 8(4):3691-700. PubMed ID: 26097550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BTG2 loss and miR-21 upregulation contribute to prostate cell transformation by inducing luminal markers expression and epithelial-mesenchymal transition.
    Coppola V; Musumeci M; Patrizii M; Cannistraci A; Addario A; Maugeri-Saccà M; Biffoni M; Francescangeli F; Cordenonsi M; Piccolo S; Memeo L; Pagliuca A; Muto G; Zeuner A; De Maria R; Bonci D
    Oncogene; 2013 Apr; 32(14):1843-53. PubMed ID: 22614007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of miR-200c on the migration and invasion abilities of human prostate cancer Du145 cells and the corresponding mechanism.
    Shi R; Xiao H; Yang T; Chang L; Tian Y; Wu B; Xu H
    Front Med; 2014 Dec; 8(4):456-63. PubMed ID: 25363395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.